This company has been marked as potentially delisted and may not be actively trading. Deep Medicine Acquisition (DMAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DMAQ vs. IMTE, AQB, SPGC, YMAT, SONY, GOLF, PTON, YETI, ARLO, and KNShould you be buying Deep Medicine Acquisition stock or one of its competitors? The main competitors of Deep Medicine Acquisition include Integrated Media Technology (IMTE), AquaBounty Technologies (AQB), Sacks Parente Golf (SPGC), J-Star (YMAT), Sony Group (SONY), Acushnet (GOLF), Peloton Interactive (PTON), YETI (YETI), Arlo Technologies (ARLO), and Knowles (KN). These companies are all part of the "recreation" industry. Deep Medicine Acquisition vs. Its Competitors Integrated Media Technology AquaBounty Technologies Sacks Parente Golf J-Star Sony Group Acushnet Peloton Interactive YETI Arlo Technologies Knowles Deep Medicine Acquisition (NASDAQ:DMAQ) and Integrated Media Technology (NASDAQ:IMTE) are both small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, community ranking, dividends, analyst recommendations and institutional ownership. Is DMAQ or IMTE more profitable? Company Net Margins Return on Equity Return on Assets Deep Medicine AcquisitionN/A N/A N/A Integrated Media Technology N/A N/A N/A Does the MarketBeat Community prefer DMAQ or IMTE? Deep Medicine Acquisition and Integrated Media Technology both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformDeep Medicine AcquisitionN/AN/AIntegrated Media TechnologyN/AN/A Which has more risk & volatility, DMAQ or IMTE? Deep Medicine Acquisition has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Integrated Media Technology has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Do insiders & institutionals have more ownership in DMAQ or IMTE? 18.4% of Deep Medicine Acquisition shares are held by institutional investors. 1.7% of Deep Medicine Acquisition shares are held by company insiders. Comparatively, 2.1% of Integrated Media Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher earnings & valuation, DMAQ or IMTE? Deep Medicine Acquisition has higher earnings, but lower revenue than Integrated Media Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDeep Medicine AcquisitionN/AN/AN/AN/AN/AIntegrated Media Technology$113.20K32.55-$16.73MN/AN/A Does the media prefer DMAQ or IMTE? In the previous week, Integrated Media Technology had 2 more articles in the media than Deep Medicine Acquisition. MarketBeat recorded 2 mentions for Integrated Media Technology and 0 mentions for Deep Medicine Acquisition. Integrated Media Technology's average media sentiment score of 1.32 beat Deep Medicine Acquisition's score of 0.00 indicating that Integrated Media Technology is being referred to more favorably in the news media. Company Overall Sentiment Deep Medicine Acquisition Neutral Integrated Media Technology Positive SummaryIntegrated Media Technology beats Deep Medicine Acquisition on 5 of the 6 factors compared between the two stocks. Get Deep Medicine Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DMAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAQ vs. The Competition Export to ExcelMetricDeep Medicine AcquisitionHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$914K$482.13M$2.55B$8.51BDividend YieldN/A7.68%13.02%4.16%P/E RatioN/A2.5011.6719.65Price / SalesN/A80.163,130,852.87152.18Price / CashN/A69.0161.1334.64Price / BookN/A6.283.764.59Net IncomeN/A$35.76M-$466.93M$248.23M Deep Medicine Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAQDeep Medicine AcquisitionN/A$0.21-8.4%N/A-82.1%$914KN/A0.0093Gap DownHigh Trading VolumeIMTEIntegrated Media TechnologyN/A$1.11+3.2%N/A-35.7%$3.83M$113.20K0.0010Gap UpAQBAquaBounty Technologies0.8604 of 5 stars$0.81-0.9%N/A-54.2%$3.13M$1.26M-0.04100Short Interest ↓SPGCSacks Parente GolfN/AN/AN/AN/A$180K$2.49M-0.0318Gap DownHigh Trading VolumeYMATJ-StarN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeSONYSony Group1.4931 of 5 stars$26.33-1.3%$28.00+6.4%+669.9%$159.22B$12.96T21.37108,900Short Interest ↑GOLFAcushnet2.8976 of 5 stars$70.77-0.6%$70.00-1.1%+8.7%$4.16B$2.45B24.077,300PTONPeloton Interactive3.671 of 5 stars$6.94-7.1%$8.30+19.6%+87.6%$2.71B$2.53B-9.019,770News CoverageYETIYETI3.8379 of 5 stars$31.39-1.2%$39.40+25.5%-27.8%$2.60B$1.84B15.24920Positive NewsARLOArlo Technologies2.2246 of 5 stars$16.17+10.7%$20.25+25.3%+29.7%$1.68B$505.75M-64.66350High Trading VolumeKNKnowles1.1678 of 5 stars$16.64flat$19.33+16.2%-6.1%$1.45B$552.40M-6.287,000 Related Companies and Tools Related Companies Integrated Media Technology Alternatives AquaBounty Technologies Alternatives Sacks Parente Golf Alternatives J-Star Alternatives Sony Group Alternatives Acushnet Alternatives Peloton Interactive Alternatives YETI Alternatives Arlo Technologies Alternatives Knowles Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAQ) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deep Medicine Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Deep Medicine Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
